FindTrial
Sign In

Estimated number of patients with chronic refractory gout using real-world data from the United States

Estimated number of patients with chronic refractory gout using real-world data from the United States - Estimated number of patients with chronic refractory gout

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000045786
Enrollment
Unknown
Registered
2021-10-18
Start date
2021-10-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gout

Interventions

None listed

Sponsors

Teijin Pharma Limited
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Analysis target population is patients with chronic refractory gout. Analysis for gout patients will also be performed. The definitions of analysis target population in the MarketScan Commercial database are as follows. 1. Patients with gout in 2019, and 2. Patients with continuous insurance coverage, and 3. Patients aged 0-64 at the end of 2019, and 4. Patients with chronic refractory gout Analysis target population in the Medicare 5% sample databases is gout diagnosed patients aged 65 years or older.

Exclusion criteria

Exclusion criteria: N.A.

Design outcomes

Primary

MeasureTime frame
Number of patients with chronic refractory gout and its proportion to the population—

Secondary

MeasureTime frame
Number of gout patients and its proportion to the population Characteristics, treatment status and disease burden of patients with gout and chronic refractory gout—

Countries

Japan,North America

Contacts

Public ContactRuriko Koto

Teijin Pharma Limited Medical Science Department

tpm-com@umin.ac.jp03-3506-4140

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026